4.4 Article

Mathematical Model of Triple-Negative Breast Cancer in Response to Combination Chemotherapies

期刊

BULLETIN OF MATHEMATICAL BIOLOGY
卷 85, 期 1, 页码 -

出版社

SPRINGER
DOI: 10.1007/s11538-022-01108-1

关键词

Doxorubicin; Paclitaxel; Sobol'; Sensitivity analysis; MDA-MB-231

向作者/读者索取更多资源

Triple-negative breast cancer (TNBC) is a heterogeneous disease characterized by the absence of targetable receptors, resulting in limited treatment options and higher rates of metastasis and recurrence. In this study, a mathematical model using ordinary differential equations is developed to describe the response of TNBC to combination chemotherapy with doxorubicin and paclitaxel. The model is parameterized using noninvasive molecular imaging data and validated with histological data from two murine models. The model accurately predicts tumor volume changes and necrosis volume, providing insights into the effectiveness of different treatment strategies and the role of the immune system in TNBC.
Triple-negative breast cancer (TNBC) is a heterogenous disease that is defined by its lack of targetable receptors, thus limiting treatment options and resulting in higher rates of metastasis and recurrence. Combination chemotherapy treatments, which inhibit tumor cell proliferation and regeneration, are a major component of standard-of-care treatment of TNBC. In this manuscript, we build a coupled ordinary differential equation model of TNBC with compartments that represent tumor proliferation, necrosis, apoptosis, and immune response to computationally describe the biological tumor affect to a combination of chemotherapies, doxorubicin (DRB) and paclitaxel (PTX). This model is parameterized using longitudinal [F-18]-fluorothymidine positron emission tomography (FLT-PET) imaging data which allows for a noninvasive molecular imaging approach to quantify the tumor proliferation and tumor volume measurements for two murine models of TNBC. Animal models include a human cell line xenograft model, MDA-MB-231, and a syngeneic 4T1 mammary carcinoma model. The mathematical models are parameterized and the percent necrosis at the end time point is predicted and validated using histological hematoxylin and eosin (H & E) data. Global Sobol' sensitivity analysis is conducted to further understand the role each parameter plays in the model's goodness of fit to the data. In both the MDA-MB-231 and the 4T1 tumor models, the designed mathematical model can accurately describe both tumor volume changes and final necrosis volume. This can give insight into the ordering, dosing, and timing of DRB and PTX treatment. More importantly, this model can also give insight into future novel combinations of therapies and how the immune system plays a role in therapeutic response to TNBC, due to its calibration to two types of TNBC murine models.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据